[ad_1]
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann
ZURICH (Reuters) – Drugmaker Roche has received emergency use authorisation from the U.S. Food and Drug Administration for its Elecsys IL-6 test to help identify severe inflammatory response in patients with confirmed COVID-19, it said on Thursday.
The test can be used to help identify coronavirus patients who could be at high risk of intubation with mechanical ventilation, helping doctors decide early on if ventilation could be required, Roche said.
Reporting by Brenna Hughes Neghaiwi; Editing by Michael Shields
Our Standards:The Thomson Reuters Trust Principles.
[ad_2]
Source link